[Clyde Apac] Product Overview

APPLICATIONS

Cytotoxic drug safety cabinets are defined in Australian Standard AS2252.5 as the primary barrier against exposure to aerosols that are produced in the preparation, manipulation and dispensing of cytotoxic drugs. Many of these drugs are known to be mutagens and are suspected of being carcinogens and teratogens. Recent work involving prions has proven that exposure may result in effects that are insidious and may not manifest themselves for some years. The requirements for protection involve the following: • Protection of cabinet users and other staff from exposure to aerosols or vapours which may be generated in the preparation, manipulation, and dispensing of cytotoxic drugs; • Protection of drug products, so that they may be prepared in an environment which is essentially free from particulate and biological contamination; • Protection of cabinet maintenance personnel from the residue of drug particles which can contaminate filters, fans and other mechanical components.

DESCRIPTION

CG2010 CytogardTM drug safety cabinets are designed and manufactured in Australia in three nominal widths – a 900mm, 1200mm and 1800mm – and fully comply with all requirements of Australian Standard AS2252.5. Cytotoxic cabinets are necessary for operator and product protection, in addition to the safe guards provided by an effective air barrier and Clyde-Apac Microseal TM HEPA filter technology, CG2010 series is also equipped with a carbon filter to remove harmful vapours that may be released during the compounding process. CG2010 series are essential for the protection of personnel, product and the environment.

AES Environmental maintains an ISO 9001:2008 quality management system to ensure process and product conformance.

Powered by